Status Migrainosus - Differentiating Between Responders and Non-responders in the Setup of Real-life Clinical Practice
Phase of Trial: Phase I/II
Latest Information Update: 03 Sep 2018
At a glance
- Drugs Bupivacaine (Primary) ; Dexamethasone (Primary) ; Ketorolac (Primary) ; Ketorolac (Primary) ; Naratriptan (Primary)
- Indications Migraine without aura
- Focus Proof of concept; Therapeutic Use
- 31 Jul 2018 Planned End Date changed from 30 Jun 2018 to 30 Jun 2020.
- 31 Jul 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2019.
- 03 Mar 2017 New trial record